首页> 外文期刊>Pharmaceutical development and technology >Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design
【24h】

Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design

机译:使用纳米沉淀技术开发具有高度捕获性的草药亲水性药物的聚合物纳米颗粒:一种通过设计实现质量的方法

获取原文
获取原文并翻译 | 示例
           

摘要

The intention of this study is to achieve higher entrapment efficiency (EE) of berberine chloride (selected hydrophilic drug) using nanoprecipitation technique. The solubility of drug was studied in various pH buffers (1.2-7.2) for selection of aqueous phase and stabilizer. Quality by design (QbD)-based 3(2) factorial design were employed for optimization of formulation variables; drug to polymer ratio (X-1) and surfactant concentration (X-2) on entrapment efficiency (EE), particle size (PS) and polydispersity index (PDI) of the nanoparticles. The nanoparticles were subjected to solid state analysis, in vitro drug release and stability study. The aqueous phase and stabilizer selected for the formulations were pH 4.5 phthalate buffer and surfactant F-68, respectively. The formulation (F-6) containing drug to polymer ratio (1:3) and stabilizer (F-68) concentration of 50 mM exhibited best EE (82.12%), PS (196.71 nm), PDI (0.153). The various solid state characterizations assured that entrapped drug is amorphous and nanoparticles are fairly spherical in shape. In vitro drug release of the F-6 exhibited sustained release with non-Fickian diffusion and stable at storage condition. This work illustrates that the proper selection of aqueous phase and optimization of formulation variables could be helpful in improving the EE of hydrophilic drugs by nanoprecipitation technique.
机译:这项研究的目的是使用纳米沉淀技术实现更高的氯化小ber碱(选定的亲水性药物)的包封率(EE)。在各种pH缓冲液(1.2-7.2)中研究了药物的溶解度,以选择水相和稳定剂。基于设计质量(QbD)的3(2)析因设计用于优化配方变量。药物与聚合物的比例(X-1)和表面活性剂浓度(X-2)对纳米颗粒的包封率(EE),粒径(PS)和多分散指数(PDI)的影响。对纳米颗粒进行固态分析,体外药物释放和稳定性研究。选择用于制剂的水相和稳定剂分别是pH 4.5的邻苯二甲酸盐缓冲剂和表面活性剂F-68。包含药物与聚合物之比(1:3)和稳定剂(F-68)浓度为50 mM的制剂(F-6)表现出最佳的EE(82.12%),PS(196.71 nm),PDI(0.153)。各种固态特征确保了截留的药物是无定形的,纳米颗粒的形状相当球形。 F-6的体外药物释放表现出持续的释放,且非Fickian扩散且在储存条件下稳定。这项工作说明水相的正确选择和配方变量的优化可能有助于通过纳米沉淀技术改善亲水性药物的EE。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号